Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1975 Jan;25(1):117-20.

[Effect of methylpyrazole-carboxylic acid on carbohydrate and lipid metabolisms in patients with diabetes mellitus]

[Article in German]
  • PMID: 807221

[Effect of methylpyrazole-carboxylic acid on carbohydrate and lipid metabolisms in patients with diabetes mellitus]

[Article in German]
P D Lang et al. Arzneimittelforschung. 1975 Jan.

Abstract

The effect of 3-methylpyrazole-5-carboxylic acid (MPC) on carbohydrate and lipid metabolisms was studied in 18 patients with diabetes mellitus. In addition to diet 17 patients had basic treatment with sulfonylureas with or without biguanides, one patient was treated with insulin. In all patients carbohydrate metabolism was not well controlled, 14 patients had elevated triglycerides. Following a control period of 2 weeks the patients received increasing doses of MPC in addition to basic treatment (25825825 mg; 50,25,25 mg; 50, 50, 25 mg). Blood samples were taken in the fasting state before the first dose of MPC. Free fatty acids almost doubled under the influence of MPC. This was due to a rebound effect at night following suppression of lipolysis during the day. Blood glucose levels showed a tendency to fall, urinary glucose excretion, separately examined for day and night ,did not change consistently. Triglycerides fell markedly by 25%, but this reduction was not statistically significant. Cholesterol decreased by 5%. 40% of the patients showed an increase in urinary ketone bodies. Body weight did not change. Side effects due to MPC included flushing, gastrointestinal distress and cardiovascular complaints and were observed in 75% of the patients. Due to the high frequency of side effects it does not seem to be worthwhile to further investigate the therapeutic effect of MPC in a larger number of patients with different dosage regimens.

PubMed Disclaimer

Publication types

MeSH terms